News

Pulmonary Hypertension Patient Day
5th December 2016

Pulmonary Hypertension Patient Day

The Pulmonary Hypertension Association UK held a meeting for patients, their families, and staff from the Royal Hallamshire Hospital Pulmonary Vascular Disease Unit on 12th November at the Hilton Hotel in Sheffield. Staff from the PVDU gave presen...

Read More

New Trial of treatment for people with Idiopathic Pulmonary Fibrosis
5th December 2016

New Trial of treatment for people with Idiopathic Pulmonary Fibrosis

The STH Interstitial Lung Disease service led by Dr Stephen Bianchi has initiated a clinical trial sponsored by Boehringer-Ingelheim. The trial will investigate if combining two drugs, Nintedanib and Sildenafil, is effective in treatment of idiopa...

Read More

New clinical trial of treatment for Severe Asthma
5th December 2016

New clinical trial of treatment for Severe Asthma

Prof Ian Sabroe and the RHH Clinical Research Facility have initiated a clinical trial investigating Fevipiprant, a new treatment which can be taken orally as a tablet, developed by Novartis for people with severe asthma. Previous research has sho...

Read More

Patient and Public Involvement in Research Newsletter
7th October 2016

Patient and Public Involvement in Research Newsletter

the Sheffield Clinical Research Office has published its third Newsletter about Patient and Public Involvement in clinical research. Click here for details http://www.lungsheffield.org/files/document/39/PPI%20Newsletter%203rd%20ed..pdf

Read More

New trial using advanced MR Imaging to investigate effect of inhaled treatments for COPD
5th September 2016

New trial using advanced MR Imaging to investigate effect of inhaled treatments for COPD

A trial sponsored by Novartis will build on previous research involving STH Respiratory Medicine (Dr Rod Lawson) and the University of Sheffield (Prof Jim Wild). The trial will study the effects of a combination inhaled drug therapy (LABA/LAMA) in...

Read More

First pulmonary denervation in the UK takes place at Sheffield Teaching Hospitals
17th August 2016

First pulmonary denervation in the UK takes place at Sheffield Teaching Hospitals

A team from Sheffield Teaching Hospitals have trialled a new treatment procedure for people with pulmonary hypertension, a condition affecting the lungs and heart. Dr Alex Rothman and a research team from the directorates of Cardiology, Respirator...

Read More

Sheffield cystic fibrosis research team win award at international conference
17th June 2016

Sheffield cystic fibrosis research team win award at international conference

Dr Hui Hoo, who is funded by an NIHR Research Fellowship, has won a poster prize at the International European Cystic Fibrosis Conference. This important award reflects the recognition that this work represents a way to shift CF care from expensi...

Read More

International Clinical Trials Day
16th May 2016

International Clinical Trials Day

International Clinical Trials Day commemorates the day in 1747 that James Lind started his trial on the deadly disease scurvy. The trial consisted of 12 sailors with scurvy, given a variety of dietary supplements from cider to oranges and lemons. ...

Read More

New study: Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
6th May 2016

New study: Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

New study: A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension Inflammation and autoimmunity have an important role in Pulmonary Hypertension, a serious condition characterised by raised blood pressur...

Read More

New study: Assessing Idiopathic Lung Fibrosis with MR Imaging
1st March 2016

New study: Assessing Idiopathic Lung Fibrosis with MR Imaging

Idiopathic pulmonary fibrosis (IPF) is a lung disease with no known cure, in spite of recent antifibrotic treatment advances. Lung magnetic resonance imaging (MRI) has shown early promise as a tool in helping to understand microstructural, functio...

Read More